Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Paediatric Sarcoma, Hybrid Imaging & FAPI - An Investigator-initiated, Non-inferiority, Single-group, Phase II Clinical Trial, Evaluating FAPI WB PET/MRI at Primary Staging, Treatment Control and Relapse in Paediatric Sarcoma - The PsiFI Trial

NCT07861217 is registered in ClinicalTrials.gov with Copenhagen University Hospital, Rigshospitalet as lead sponsor.

NCT NCT07861217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07861217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Paediatric Sarcoma, Hybrid Imaging & FAPI - An Investigator-initiated, Non-inferiority, Single-group, Phase II Clinical Trial, Evaluating FAPI WB PET/MRI at Primary Staging, Treatment Control and Relapse in Paediatric Sarcoma - The PsiFI Trial
Lead sponsor
Copenhagen University Hospital, Rigshospitalet
Phase
Phase 2
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
June 30, 2029
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma